183 related articles for article (PubMed ID: 25616525)
1. Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.
Unzueta U; Vázquez F; Accardi G; Mendoza R; Toledo-Rubio V; Giuliani M; Sannino F; Parrilli E; Abasolo I; Schwartz S; Tutino ML; Villaverde A; Corchero JL; Ferrer-Miralles N
Appl Microbiol Biotechnol; 2015 Jul; 99(14):5863-74. PubMed ID: 25616525
[TBL] [Abstract][Full Text] [Related]
2. Recombinant production of a single-chain antibody fragment in Pseudoalteromonas haloplanktis TAC125.
Giuliani M; Parrilli E; Sannino F; Apuzzo GA; Marino G; Tutino ML
Appl Microbiol Biotechnol; 2014 Jun; 98(11):4887-95. PubMed ID: 24535258
[TBL] [Abstract][Full Text] [Related]
3. Recombinant protein production in Antarctic Gram-negative bacteria.
Duilio A; Tutino ML; Marino G
Methods Mol Biol; 2004; 267():225-37. PubMed ID: 15269427
[TBL] [Abstract][Full Text] [Related]
4. Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Colarusso A; Lauro C; Calvanese M; Parrilli E; Tutino ML
Microb Cell Fact; 2022 Oct; 21(1):211. PubMed ID: 36242022
[TBL] [Abstract][Full Text] [Related]
5. Soluble recombinant protein production in Pseudoalteromonas haloplanktis TAC125.
Giuliani M; Parrilli E; Sannino F; Apuzzo G; Marino G; Tutino ML
Methods Mol Biol; 2015; 1258():243-57. PubMed ID: 25447868
[TBL] [Abstract][Full Text] [Related]
6. Optimization of recombinant human nerve growth factor production in the psychrophilic Pseudoalteromonas haloplanktis.
Vigentini I; Merico A; Tutino ML; Compagno C; Marino G
J Biotechnol; 2006 Dec; 127(1):141-50. PubMed ID: 16859797
[TBL] [Abstract][Full Text] [Related]
7. A novel synthetic medium and expression system for subzero growth and recombinant protein production in Pseudoalteromonas haloplanktis TAC125.
Sannino F; Giuliani M; Salvatore U; Apuzzo GA; de Pascale D; Fani R; Fondi M; Marino G; Tutino ML; Parrilli E
Appl Microbiol Biotechnol; 2017 Jan; 101(2):725-734. PubMed ID: 27796433
[TBL] [Abstract][Full Text] [Related]
8. An effective cold inducible expression system developed in Pseudoalteromonas haloplanktis TAC125.
Papa R; Rippa V; Sannia G; Marino G; Duilio A
J Biotechnol; 2007 Jan; 127(2):199-210. PubMed ID: 16959351
[TBL] [Abstract][Full Text] [Related]
9. Optimization of cold-adapted alpha-galactosidase expression in Escherichia coli.
Golotin VA; Balabanova LA; Noskova YA; Slepchenko LV; Bakunina IY; Vorobieva NS; Terenteva NA; Rasskazov VA
Protein Expr Purif; 2016 Jul; 123():14-8. PubMed ID: 27033343
[TBL] [Abstract][Full Text] [Related]
10. Advanced genetic strategies for recombinant protein expression in Escherichia coli.
Sørensen HP; Mortensen KK
J Biotechnol; 2005 Jan; 115(2):113-28. PubMed ID: 15607230
[TBL] [Abstract][Full Text] [Related]
11. Soluble Recombinant Protein Production in Pseudoalteromonas haloplanktis TAC125: The Case Study of the Full-Length Human CDKL5 Protein.
Calvanese M; Colarusso A; Lauro C; Parrilli E; Tutino ML
Methods Mol Biol; 2022; 2406():219-232. PubMed ID: 35089560
[TBL] [Abstract][Full Text] [Related]
12. Development of high-copy number plasmids in Pseudoalteromonas haloplanktis TAC125.
Calvanese M; Balestra C; Colarusso A; Lauro C; Riccardi C; Fondi M; Parrilli E; Tutino ML
Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2469-2481. PubMed ID: 36912903
[TBL] [Abstract][Full Text] [Related]
13. Regulated recombinant protein production in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Rippa V; Papa R; Giuliani M; Pezzella C; Parrilli E; Tutino ML; Marino G; Duilio A
Methods Mol Biol; 2012; 824():203-18. PubMed ID: 22160900
[TBL] [Abstract][Full Text] [Related]
14. Tools to cope with difficult-to-express proteins.
Saccardo P; Corchero JL; Ferrer-Miralles N
Appl Microbiol Biotechnol; 2016 May; 100(10):4347-55. PubMed ID: 27079572
[TBL] [Abstract][Full Text] [Related]
15. Large-scale biofilm cultivation of Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 for physiologic studies and drug discovery.
Parrilli E; Ricciardelli A; Casillo A; Sannino F; Papa R; Tilotta M; Artini M; Selan L; Corsaro MM; Tutino ML
Extremophiles; 2016 Mar; 20(2):227-34. PubMed ID: 26847199
[TBL] [Abstract][Full Text] [Related]
16. Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.
Sharma A; Chaudhuri TK
Microb Cell Fact; 2017 Oct; 16(1):173. PubMed ID: 28982367
[TBL] [Abstract][Full Text] [Related]
17. [High expression of alpha-D-galactosidase gene (aga1) of Bifidobacterium breve 203 in Escherichia coli].
Lu Y; Zhao H; Wang QP; Liu WF; Xiao M
Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):241-6. PubMed ID: 15989269
[TBL] [Abstract][Full Text] [Related]
18. Genome-scale metabolic reconstruction and constraint-based modelling of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Fondi M; Maida I; Perrin E; Mellera A; Mocali S; Parrilli E; Tutino ML; Liò P; Fani R
Environ Microbiol; 2015 Mar; 17(3):751-66. PubMed ID: 24889559
[TBL] [Abstract][Full Text] [Related]
19. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
[TBL] [Abstract][Full Text] [Related]
20. Development of an improved Pseudoalteromonas haloplanktis TAC125 strain for recombinant protein secretion at low temperature.
Parrilli E; De Vizio D; Cirulli C; Tutino ML
Microb Cell Fact; 2008 Feb; 7():2. PubMed ID: 18257924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
